Clinical Trial Update: Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating nebulized AER 001 in atopic allergic asthma patients during antigen challenge.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• AER 001

Snippet

Sponsor: Aerovance, Inc. | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED